192 related articles for article (PubMed ID: 34659892)
1. Induction of cellular senescence in fibroblasts through β1-integrin activation by tenascin-C-derived peptide and its protumor effect.
Fujita M; Sasada M; Eguchi M; Iyoda T; Okuyama S; Osawa T; Tsuzuranuki K; Sakamoto M; Hagihara Y; Matsumura M; Osada S; Kodama H; Higami Y; Fukai F
Am J Cancer Res; 2021; 11(9):4364-4379. PubMed ID: 34659892
[TBL] [Abstract][Full Text] [Related]
2. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.
Fujita M; Ito-Fujita Y; Iyoda T; Sasada M; Okada Y; Ishibashi K; Osawa T; Kodama H; Fukai F; Suzuki H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195598
[TBL] [Abstract][Full Text] [Related]
3. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
[TBL] [Abstract][Full Text] [Related]
4. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation.
Fujita M; Sasada M; Iyoda T; Nagai R; Kudo C; Yamamoto T; Osada S; Kodama H; Fukai F
Biochem Biophys Res Commun; 2021 Jan; 536():14-19. PubMed ID: 33360093
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.
Tanaka R; Seki Y; Saito Y; Kamiya S; Fujita M; Okutsu H; Iyoda T; Takai T; Owaki T; Yajima H; Taira J; Hayashi R; Kodama H; Matsunaga T; Fukai F
J Biol Chem; 2014 Jun; 289(25):17699-708. PubMed ID: 24808173
[TBL] [Abstract][Full Text] [Related]
6. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.
Saito Y; Shiota Y; Nishisaka M; Owaki T; Shimamura M; Fukai F
Biol Pharm Bull; 2008 May; 31(5):1003-7. PubMed ID: 18451535
[TBL] [Abstract][Full Text] [Related]
8. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression.
Fujita M; Suzuki H; Fukai F
World J Gastrointest Oncol; 2021 Sep; 13(9):980-994. PubMed ID: 34616507
[TBL] [Abstract][Full Text] [Related]
9. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4.
Saito Y; Imazeki H; Miura S; Yoshimura T; Okutsu H; Harada Y; Ohwaki T; Nagao O; Kamiya S; Hayashi R; Kodama H; Handa H; Yoshida T; Fukai F
J Biol Chem; 2007 Nov; 282(48):34929-37. PubMed ID: 17901052
[TBL] [Abstract][Full Text] [Related]
10. Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
Iyoda T; Fujita M; Fukai F
Front Immunol; 2020; 11():610096. PubMed ID: 33362799
[TBL] [Abstract][Full Text] [Related]
11. Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation.
Iyoda T; Ohishi A; Wang Y; Yokoyama MS; Kazama M; Okita N; Inouye S; Nakagawa Y; Shimano H; Fukai F
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339104
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.
Fujita M; Sasada M; Iyoda T; Fukai F
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708610
[TBL] [Abstract][Full Text] [Related]
13. Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β.
Hassona Y; Cirillo N; Lim KP; Herman A; Mellone M; Thomas GJ; Pitiyage GN; Parkinson EK; Prime SS
Carcinogenesis; 2013 Jun; 34(6):1286-95. PubMed ID: 23358854
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.
Iyoda T; Fukai F
Int J Cell Biol; 2012; 2012():647594. PubMed ID: 22216033
[TBL] [Abstract][Full Text] [Related]
15. The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.
Suzuki H; Sasada M; Kamiya S; Ito Y; Watanabe H; Okada Y; Ishibashi K; Iyoda T; Yanaka A; Fukai F
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106752
[TBL] [Abstract][Full Text] [Related]
16. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4.
Saito Y; Owaki T; Matsunaga T; Saze M; Miura S; Maeda M; Eguchi M; Tanaka R; Taira J; Kodama H; Goto S; Niitsu Y; Terada H; Fukai F
J Biol Chem; 2010 Mar; 285(10):7006-15. PubMed ID: 20007695
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
19. Bystander senescence in human peritoneal mesothelium and fibroblasts is related to thrombospondin-1-dependent activation of transforming growth factor-β1.
Mikuła-Pietrasik J; Sosińska P; Janus J; Rubiś B; Brewińska-Olchowik M; Piwocka K; Książek K
Int J Biochem Cell Biol; 2013 Sep; 45(9):2087-96. PubMed ID: 23871936
[TBL] [Abstract][Full Text] [Related]
20. Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation.
Otsuka K; Sasada M; Hirano YU; Nohara Y; Iyoda T; Higami Y; Kodama H; Fukai F
Anticancer Res; 2019 Jul; 39(7):3487-3492. PubMed ID: 31262872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]